Granules India Company Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally.

The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors.

It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology.

The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Granules India Limited

Country	India
Founded	1984
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,066
CEO	Krishna Chigurupati

Contact Details

Address: Granules Tower Hyderabad India
Phone	91 40 6904 3500

Stock Details

Ticker Symbol	GRANULES
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE101D01020
SIC Code	2834

Key Executives

Name	Position
Dr. Krishna Prasad Chigurupati B.Sc.	Chairman and MD
Priyanka Chigurupati	Head of Marketing and Executive Director
Harsha Chigurupati BBA	Executive Director
Ramraj Rangarajalu	President and Head of Formulations Operations
Dr. P. N. Baskaran	President - Head API Manufacturing and Operations
Sanjay Kumar	President and Chief Strategy Officer
Dr. Rajesh Kapoor Ph.D.	President and Global Head of Quality
Mukesh Surana	Chief Financial Officer
Dr. P. V. Srinivas	Chief Technology Officer and Head of Research & Development
Chaitanya Tummala	Company Secretary and Compliance Officer